Recs

110

Top Stocks to Buy Today

The stock market is filled with individuals who know the price of everything, but the value of nothing.
-- Philip Fisher

Despite the recent gains in the market, current economic data suggests we shouldn't expect a full recovery anytime too soon. So it may be fair to ask ourselves: How can we avoid the mistakes that got us here, and how can we find the top stocks to buy today?

Consider this
The mistakes that led to this downturn are reminiscent of the speculative frenzy known as the Dutch Tulip Craze. In 1636, Dutch citizens found themselves caught up in a tulip rampage that lead to skyrocketing orders and prices that grew by as much as 100% per week. Eventually, one tulip bulb was selling for the equivalent of thousands of modern-day dollars! The market became overbought, and the frenzy bottomed. By 1637, the price of tulips was less than 1% of what it had been before the crash. Value was an afterthought to the tulip "day traders" who sought to profit from irrationally soaring prices.

Quickly fast-forward to the dot-com bust around 2002. The growth of Internet companies and an overinvestment in information technology caused the Nasdaq to rise more than 600% from 1994 to early 2000. If you were alive or breathing in the last 10 years, surely you remember what happened next:

  • In 18 short months, approximately $5 trillion was wiped out of the value of technology stocks.
  • Silicon Valley stalwarts like Microsoft (Nasdaq: MSFT  ) and Cisco Systems (Nasdaq: CSCO  ) both experienced price depreciations of more than 50% in a similar time period.

As with the tulips, it seemed as though everyone was confident in the price of the next "big" stock. The classic example of the overhyped company of the time was Pets.com. After trading for more than $14 per share, it liquidated in less than 270 days at $0.22 per share. Everyone supposedly knew the right price -- but what was the value?

OK, let's talk 2008
Call last year what you want. The housing horror. The derivative debacle. The commodity crisis. The securitization scare. There are too many explanations for the collapse to isolate only one aspect. For the sake of argument, I'll arbitrarily choose crude oil to illustrate my point. The Commodity Futures Trading Commission recently announced it will release a report suggesting speculators played a role in driving last year's wild swings in oil prices, which saw crude spike at $145 a barrel in July before collapsing to $33 a barrel by December, representing a 77% decline in value over a six-month period.

National Oilwell Varco (NYSE: NOV  ) , an upstream oil service provider, and Weatherford International, an oil and gas equipment provider, each lost 80% of their value from July 2008 to November 2008 ... and have gone on to double along with the recent crude oil rally. I don't mean to sound repetitive here, but from these numbers, it appears that many investors didn't evaluate these companies' competitive positions, but were instead making bets on oil prices.

What, if anything, have we learned?
We can be certain that there will always be ups and downs, booms and busts, good years and bad.

So what can we do? One philosophy is to invest in companies with great competitive advantages, clean balance sheets, and a history of success in their given industries. For example, investing in Google (Nasdaq: GOOG  ) , a company with no debt and a long history of beating analyst expectations, would certainly seem like a good idea. But at more than 30 times earnings, does it provide you with much value today? 

Similarly, Netflix (Nasdaq: NFLX  ) , the largest online movie service -- which boasts more than 10 million subscribers and has a stellar reputation for innovative management -- also seems like a solid investment. But it's currently trading at 28 times earnings -- does that provide value to someone buying shares today? It's hard to know the answers. That's why we focus not only on exciting companies, but on ones that are exuding value, as well.

Here's a place to start
In both bear and bull markets, value investing has provided people with a logical and methodical approach to investing. The general ideas: Don't speculate on questionable growth potential or companies with debatable revenue streams. Look at companies that may be trading well below their intrinsic value for unfounded reasons, seem cheap compared to their industry, and have strong records of returning capital to their shareholders.

Here a just a few companies that presently fit the bill:

Company

% Below 12-Month High

Price-to-Earnings Ratio

Return on Equity

Satyam (NYSE: SAY  ) *

77%

3.5

27%

Innophos Holdings

56%

2.2

25%**

Nokia (NYSE: NOK  )

52%

16.1

18%

Star Bulk Carriers

67%

1.4

28%

Data from Capital IQ, a division of Standard & Poor's. *Satyam financial data based on most recent 20-F filing. **Most recent quarter.

Granted, in some cases these companies' P/Es are artificially low based on last year's higher earnings. But even if earnings decline, they're still cheap.

More ideas
Our Inside Value team seeks out companies that not only have great competitive advantages (Google and Netflix, for example), but that also trade at bargain prices. If you're looking for more cheap stock ideas, you can click here to read about all of the team's official recommendations, free for 30 days.

Fool contributor Jordan DiPietro doesn't own any of the shares mentioned above, but is always looking for a discount (mostly on sneakers). Google is a Motley Fool Rule Breakers recommendation. Netflix and National Oilwell Varco are Stock Advisor picks. Microsoft and Nokia are Inside Value selections. Innophos is a Motley Fool Hidden Gems recommendation and Fool holding. If I could buy the Fool's disclosure policy at a discount, you know I would.


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On August 07, 2009, at 6:54 PM, VegasMartin wrote:

    I came across BARE in my hunt for growth stocks, with low PE's, and great balance sheets. Tremendous cash, improved its debt last quarter, growing business. Got in at $8, trading at $9.50, should be worth $15. Wish I would have came across this one in March. With a PE at 10, it's still a buy.

    www.ShootTheBears.com

  • Report this Comment On August 08, 2009, at 2:02 PM, GeoMetric wrote:

    Your missing:

    VRNM - Verenium/BP partnership called:

    http://www.vercipia.com/

    _____________________________

    SYNM - Syntroleum

  • Report this Comment On August 08, 2009, at 3:00 PM, ozzfan1317 wrote:

    Good article with some good points

    www.newsecretsoftherich.com

  • Report this Comment On August 09, 2009, at 2:56 PM, nareshsood wrote:

    The fraud hit SATYAM after take-ove by Mahindras of Tech Mahindra has turned to be 5th largest Indian IT Biggies and Satyam is regaining the confidence of its customers apart from its beoing cost effective service provider in SAP services to the industry.

  • Report this Comment On August 09, 2009, at 6:37 PM, VerySharp wrote:

    Why not include the penny stocks as well:

    BIEL @ .08

    The future of drug less pain relief. FDA approval expected. Already sold in USA, Canada, India (huge market) and many other countries.

    IDOI @ .007

    No more taking off shoes at the Airport. Shoe scanner from Israel (significant install base in sensitive places)

    VITA @ 5.27

    Bone regeneration and repair compound. FDA approved.

    CCTR @ .04

    One of China's likely next software powerhouses.

  • Report this Comment On August 09, 2009, at 7:21 PM, sadieb23 wrote:

    Does anyone have a comment on BONU. Bionuetral? IT looks like a good one to me.

  • Report this Comment On August 11, 2009, at 1:37 PM, centsndollars wrote:

    I recently was shown a GOLD mining company with the ticker LVCA. I investigated it more and more and decided to buy in at .41 cants a share. Glad I did because they recently bought KMC which held many licenses in Africa and have begun exploration. Nothing but great news coming from their work. Check it out. Now priced close to .90 cents/share.

  • Report this Comment On August 12, 2009, at 11:03 PM, MisterBruce wrote:

    FYI

    Helicos BioSciences (HLCS) Announces Publication of Breakthrough Study Using Helicos(TM) Genetic Analysis System to Sequence Human Genome

    * Helicos BioSciences Announces the First Ever Single-Molecule View of Whole Human Genome

    * Helicos BioSciences Announces the Sale of a Helicos(TM) Genetic Analysis System

    Helicos BioSciences Corporation (NASDAQ: HLCS) announced late yesterday the publication of a breakthrough study in which a Helicos(TM) Genetic Analysis System was used to sequence a human genome at the Stanford Institute for Stem Cell and Regenerative Medicine. The research article, now appearing in the on-line edition of Nature Biotechnology, demonstrates the power, accuracy and ease-of-use of the Helicos System.

    The study, conducted by Dmitry Pushkarev, Norma Neff and Stephen Quake was carried out using less than four runs of a single HeliScope(TM) Single Molecule Sequencer, and achieved 28X average coverage of the human genome. The sequencing allowed the detection of over 2.8 million single nucleotide polymorphisms, of which over 370,000 were novel. Validation with a genotyping array demonstrated 99.8% concordance. The unbiased nature of the single-molecule sequencing approach also allowed the detection of 752 copy number variations in this genome.

    "Helicos is very proud of this achievement and congratulates the Stanford group on their study; personal genome resequencing is another in a continuing series of major breakthroughs for our team as we bring the only true single-molecule sequencing available today to the market" said Ron Lowy, CEO of Helicos.

  • Report this Comment On August 14, 2009, at 1:52 PM, northjm wrote:

    Isn't the Motley Fool the same company that has been reccommending Netflix to us for the past year?

    Now they say a PE of 28 is too high? What's up?

  • Report this Comment On August 14, 2009, at 10:19 PM, marcelitoS wrote:

    I read that TEVA is buying Shire - Shire also is developing a product agains Goucher disease

    PLX is developing a similar product/ Please pay atention the General Director of PLX is Mr. Horowitz ex co-funder of TEVA/ Intresting!!!

  • Report this Comment On August 15, 2009, at 11:47 AM, Knifecatcher1 wrote:

    Satyam data provided by a cracker jacks box and a lucky 8-ball.

  • Report this Comment On March 02, 2011, at 4:26 PM, jrusso9722 wrote:

    Sadieb23,

    I just bought BONU. EPA just approved YGiene disenfectant. Every hospital, nursing home, assisted living, veterinary, exercise center, cafeteria, Military, etc. will want to have it on hand. As you know, Hospital Acquired Infection -HAI, is a major problem, and hospitals spend many millions on "Risk" and how to reduce or stop infections. I think it has to be a winner.

Add your comment.

Compare Brokers

Fool Disclosure

DocumentId: 960257, ~/Articles/ArticleHandler.aspx, 5/27/2012 12:41:58 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 1 day ago Sponsored by:
DOW 12,454.83 -74.92 -0.60%
S&P 500 1,317.82 -2.86 -0.22%
NASD 2,837.53 -1.85 -0.07%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

5/25/2012 4:01 PM
NOK $2.82 Up +0.08 +2.92%
Nokia CAPS Rating: ***
NOV $68.10 Up +0.25 +0.37%
National Oilwell V… CAPS Rating: *****
SAYCY.DL $2.64 Down +0.00 +0.00%
Satyam Computer Se… CAPS Rating: ****
NFLX $70.22 Down -0.05 -0.07%
Netflix CAPS Rating: **
CSCO $16.33 Down -0.06 -0.37%
Cisco Systems, Inc… CAPS Rating: *****
GOOG $591.53 Down -12.13 -2.01%
Google CAPS Rating: ****
MSFT $29.06 Down -0.01 -0.03%
Microsoft Corp CAPS Rating: ****

Advertisement